Maya Grosh
About Maya Grosh
Maya Grosh is the Scientific Director and CMC Team Lead at Bristol Myers Squibb, with over 25 years of experience in the biotech and pharmaceutical industry, specializing in CMC project management.
Current Role at Bristol Myers Squibb
Maya Grosh is currently the Scientific Director and CMC Team Lead at Bristol Myers Squibb. Her role involves leading the Chemistry, Manufacturing, and Controls (CMC) team, where she oversees project management efforts and ensures the advancement of various scientific projects. She brings a wealth of expertise to this position, having extensive experience in the biotech and pharmaceutical sectors. Her leadership at Bristol Myers Squibb reflects her commitment to advancing the company's scientific initiatives and ensuring the success of their projects.
Previous Roles at Bristol Myers Squibb
Before becoming the Scientific Director at Bristol Myers Squibb, Maya Grosh served as the Associate Director, CMC Team Lead from 2019 to 2022. In this role, she led CMC project management efforts for three years, working on a variety of projects that required her detailed knowledge in Chemistry, Manufacturing, and Controls. Her contributions were central to the success of the CMC team, aligning with the strategic goals of Bristol Myers Squibb.
Experience at Celgene
From 2017 to 2019, Maya Grosh worked at Celgene as the Associate Director, CMC Project Management. During her tenure, she managed numerous CMC projects and contributed to the development and manufacturing processes of key scientific initiatives. Her role at Celgene solidified her reputation as a skilled project manager and expert in the field of Chemistry, Manufacturing, and Controls.
Career at Eli Lilly and Company and ImClone Systems
Maya Grosh held key roles at Eli Lilly and Company, serving as the Associate Director, CMC Project Management from 2014 to 2017. Prior to that, she spent 15 years at ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company. There, she was the Director of Cell Line Development from 1999 to 2014. Her extensive experience in cell line development during her tenure at ImClone Systems contributed significantly to the company’s research and development initiatives.
Early Career and Experience at Schering-Plough and R.W.J. Pharmaceutical Research Institute
Maya Grosh began her career at R.W.J. Pharmaceutical Research Institute, a J&J Company, as an Associate Scientist in Upstream Development from 1992 to 1996. She then moved to Schering-Plough Research Institute in Union, NJ, where she worked as a Scientist in Process Development from 1996 to 1999. These early roles provided her with a strong foundation in process and upstream development, setting the stage for her future accomplishments in the biotech and pharmaceutical industries.